Trials / Completed
CompletedNCT05131074
Collabree: A Remote Intervention to Improve the Regularity of Medication Intake
Collabree: A Targeted Behavioral Economics-based Remote Intervention to Improve Medication Adherence in Patients With Hypertension
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 144 (actual)
- Sponsor
- Anjali Raja Beharelle · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
This is a clinical study to improve the regularity of medication intake for high blood pressure. Adult women and men who are over 50 years old, who have received a prescription drug for high blood pressure from MediService, and who have to take at least 4 tablets per day (of which at least 1 dose of medication per day is for high blood pressure) can participate in this study. The investigators intend to examine whether Collabree, a mobile phone application, is effective in supporting patients with hypertension to more successfully following their therapy plan in order to improve the regularity of medication intake. The study includes a 90-day intervention phase and a 90-day follow-up. The study does not require any therapy adjustments and no visits to a study center are necessary. The participants conduct the study independently at home. Participants will also fill out questionnaires. Participants are randomly assigned to one of 3 groups in a ratio of 1: 1: 1. Two of these groups will receive the Collabree mobile phone application.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Collabree Mobile Phone Application Medication Adherence Booster | Patients take part in a 90-day program to promote medication adherence and a 90-day follow-up through the Collabree application. Patients will receive more information as to the exact functions and use of the mobile phone application when the application is installed on their mobile phone. |
| BEHAVIORAL | Collabree Mobile Phone Application Medication Adherence Booster (simplified version) | Patients take part in a 90-day program to promote medication adherence and a 90-day follow-up through the Collabree application. Patients will receive more information as to the exact functions and use of the mobile phone application when the application is installed on their mobile phone. |
Timeline
- Start date
- 2022-03-10
- Primary completion
- 2024-08-23
- Completion
- 2024-11-24
- First posted
- 2021-11-23
- Last updated
- 2026-03-18
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT05131074. Inclusion in this directory is not an endorsement.